# Arcadia Biosciences (RKDA) — Earnings

RKDA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/rkda/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$0.85 |
| EPS estimate | −$0.54 |
| EPS surprise | −57.02% |
| Revenue surprise | −31.47% |
| Revenue | $1.3M |
| Revenue estimate | $1.9M |
| Reported | Nov 7, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1469443/000119312525272375/rkda-20250930.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 7, 2025 | −$0.54 | −$0.85 | -57.02% | $1.9M | $1.3M |
| Q2 2025 | Aug 14, 2025 | −$0.79 | −$3.26 | -312.66% | $1.6M | $1.5M |
| Q1 2025 | May 8, 2025 | −$0.98 | $1.90 | 293.88% | $1.3M | $1.2M |
| Q4 2024 | Mar 20, 2025 | −$0.89 | −$2.98 | -234.83% | $1.1M | $1.2M |
| Q3 2024 | Nov 12, 2024 | −$0.81 | −$1.18 | -45.68% | $1.4M | $1.5M |
| Q2 2024 | Aug 13, 2024 | $1.55 | $0.78 | -49.68% | $950,000.00 | $1.3M |
| Q1 2024 | May 9, 2024 | −$2.22 | −$1.78 | 19.64% | $1.2M | $1.3M |
| Q4 2023 | Mar 28, 2024 | −$2.59 | −$2.10 | 18.76% | $1.8M | $1.2M |
| Q3 2023 | Nov 9, 2023 | −$2.93 | −$1.89 | 35.49% | $1.5M | $1.6M |
| Q2 2023 | Aug 10, 2023 | −$4.85 | $0.61 | 112.59% | $1.6M | $1.4M |
| Q1 2023 | May 11, 2023 | −$6.60 | −$7.80 | -18.11% | $1.4M | $1.5M |
| Q4 2022 | Mar 30, 2023 | −$6.80 | −$6.31 | 7.21% | $2.0M | $1.0M |
| Q3 2022 | Nov 10, 2022 | −$8.40 | −$4.80 | 42.86% | $2.7M | $1.9M |
| Q2 2022 | Aug 11, 2022 | −$11.60 | −$6.80 | 41.38% | $2.3M | $3.9M |
| Q1 2022 | May 12, 2022 | −$13.60 | −$8.59 | 36.83% | $1.9M | $3.2M |
| Q4 2021 | Mar 30, 2022 | −$12.00 | −$16.80 | -40.00% | $3.3M | $2.2M |
| Q3 2021 | Nov 15, 2021 | −$11.80 | $6.64 | 156.28% | $2.5M | $2.4M |
| Q2 2021 | Aug 16, 2021 | −$10.93 | −$13.83 | -26.54% | $1.7M | $1.4M |
| Q1 2021 | May 17, 2021 | −$13.73 | $4.40 | 132.04% | $734,333.00 | $828,000.00 |
| Q4 2020 | Mar 30, 2021 | −$16.40 | $36.00 | 319.51% | $1.3M | $7.1M |

## Frequently Asked Questions

### When did Arcadia Biosciences (RKDA) last report earnings?

Arcadia Biosciences last reported on Nov 7, 2025, covering fiscal Q3 2025.

### Did RKDA beat earnings estimates?

No. Arcadia Biosciences reported EPS of −$0.85 for Q3 2025 against a −$0.54 estimate — a 57.02% miss.

### How much revenue did RKDA report last quarter?

Arcadia Biosciences reported $1.3M in revenue for Q3 2025, against a consensus estimate of $1.9M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).